GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atomo Diagnostics Ltd (ASX:AT1) » Definitions » ROC (Joel Greenblatt) %

Atomo Diagnostics (ASX:AT1) ROC (Joel Greenblatt) % : -164.82% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Atomo Diagnostics ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Atomo Diagnostics's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -164.82%.

The historical rank and industry rank for Atomo Diagnostics's ROC (Joel Greenblatt) % or its related term are showing as below:

ASX:AT1' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -199.29   Med: -98.53   Max: -71.07
Current: -167.38

During the past 5 years, Atomo Diagnostics's highest ROC (Joel Greenblatt) % was -71.07%. The lowest was -199.29%. And the median was -98.53%.

ASX:AT1's ROC (Joel Greenblatt) % is ranked worse than
76.59% of 850 companies
in the Medical Devices & Instruments industry
Industry Median: 1.75 vs ASX:AT1: -167.38

Atomo Diagnostics's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Atomo Diagnostics ROC (Joel Greenblatt) % Historical Data

The historical data trend for Atomo Diagnostics's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atomo Diagnostics ROC (Joel Greenblatt) % Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
ROC (Joel Greenblatt) %
-71.07 -98.53 -83.22 -199.29 -180.26

Atomo Diagnostics Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only -194.61 -193.90 -172.65 -169.32 -164.82

Competitive Comparison of Atomo Diagnostics's ROC (Joel Greenblatt) %

For the Medical Devices subindustry, Atomo Diagnostics's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atomo Diagnostics's ROC (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Atomo Diagnostics's ROC (Joel Greenblatt) % falls into.


;
;

Atomo Diagnostics ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.249 + 1.839 + 0) - (0.774 + 0.05 + 0.279)
=1.985

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.239 + 1.786 + 0.00099999999999945) - (0.744 + 0 + 0.776)
=1.506

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Atomo Diagnostics for the quarter that ended in Dec. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-5.504/( ( (1.717 + max(1.985, 0)) + (1.471 + max(1.506, 0)) )/ 2 )
=-5.504/( ( 3.702 + 2.977 )/ 2 )
=-5.504/3.3395
=-164.82 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atomo Diagnostics  (ASX:AT1) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Atomo Diagnostics ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Atomo Diagnostics's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Atomo Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Atomo Diagnostics Headlines

No Headlines